Advancing the Treatment of Anxiety Disorders: New Findings and Novel Uses for Atypical Antipsychotics

Anxiety disorders are among the most prevalent and disabling psychiatric diagnoses in our society, yet in many ways they remain among the least well-understood of the major mental illnesses. The anxiety disorders are an open avenue for investigation across many different domains of basic science and clinical research, particularly in the areas of vulnerability and resilience, treatment refractoriness, special populations, and discovery of novel therapeutic approaches. This publication reviews new findings in the field of anxiety disorder research with an emphasis on the environmental and neurobiological basis of vulnerability and the unmet needs in treatment.